Metastatic patterns of breast cancer subtypes: What radiologists should know in the era of personalized cancer medicine

Clinical Radiology

Volumn 70, Issue 1, 2015, Pages 1-10

  Chikarmane, S A ^a,b   Tirumani, S H ^a,b   Howard, S A ^a,b   Jagannathan, J P ^a,b   Dipiro, P J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; GADOXETIC ACID; PROGESTERONE RECEPTOR; TRASTUZUMAB; ESTROGEN RECEPTOR; TUMOR MARKER;

BONE METASTASIS; BONE SCINTISCANNING; BRAIN METASTASIS; BREAST CANCER; BREAST METASTASIS; CANCER PROGNOSIS; CANCER RECURRENCE; CENTRAL NERVOUS SYSTEM METASTASIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; GENE EXPRESSION; GENE MUTATION; HUMAN; LIVER METASTASIS; LUNG METASTASIS; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; RADIOLOGIST; REVIEW; TRIPLE NEGATIVE BREAST CANCER; BONE TUMOR; BREAST TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; FEMALE; GENETICS; LIVER TUMOR; LUNG TUMOR; PATHOLOGY; PERSONALIZED MEDICINE; PLEURA TUMOR; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PROTO ONCOGENE; RISK FACTOR; SECONDARY; TUMOR SUPPRESSOR GENE;

BONE NEOPLASMS; BREAST NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; FEMALE; GENES, BRCA1; GENES, ERBB-2; HUMANS; INDIVIDUALIZED MEDICINE; LIVER NEOPLASMS; LUNG NEOPLASMS; NEOPLASM METASTASIS; PLEURAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84916939679     PISSN: 00099260     EISSN: 1365229X     Source Type: Journal    
DOI: 10.1016/j.crad.2014.08.015     Document Type: Review

References (66)

1. American Cancer Society: Breast Cancer Facts and Figures. Internet 2013.
2. Cancer research UK statistics 2014
3. National Cancer Institute SEER fact sheet for breast cancer http://seer.cancer.gov/statfacts/html/breast.html 2013 [accessed 24.09.14]
4. C.M. Perou, T. Sorlie, and M.B. Eisen Molecular portraits of human breast tumours Nature 406 6797 2000 747 752
5. T. Foukakis, G. Astrom, and L. Lindstrom When to order a biopsy to characterise a metastatic relapse in breast cancer Ann Oncol 23 Suppl. 10 2012 x349 x353
6. C.B. Winston, O. Hadar, and J.B. Teitcher Metastatic lobular carcinoma of the breast: patterns of spread in the chest, abdomen, and pelvis on CT. AJR Am J Roentgenol 175 2000 795 800
7. M. Brookes, D. MacVicar, and J. Husband Metastatic carcinoma of the breast: the appearances of metastatic spread to the abdomen and pelvis as demonstrated by CT Br J Radiol 80 2007 284 292
8. D.D. Maki, and R.I. Grossman Patterns of disease spread in metastatic breast carcinoma: influence of estrogen and progesterone receptor status AJNR Am J Neuroradiol 21 2000 1064 1066
9. T. Sorlie, C.M. Perou, and R. Tibshirani Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 2001 10869 10874
10. S.L. Robbins, V. Kumar, and R.S. Cotran Robbins and Cotran pathologic basis of disease 8th ed. 2010 Saunders Philadelphia, PA
11. K.A. Cadoo, M.N. Fornier, and P.G. Morris Biological subtypes of breast cancer: current concepts and implications for recurrence patterns Q J Nucl Med Mol Imaging 57 2013 312 321
12. D.J. Slamon, B. Leyland-Jones, and S. Shak Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 New Engl J Med 344 2001 783 792
13. M. Morrow Personalizing extent of breast cancer surgery according to molecular subtypes Breast 22 Suppl. 2 2013 S106 S109
14. M.C. Figueroa-Magalhaes, D. Jelovac, and R.M. Connolly Treatment of HER2-positive breast cancer Breast 23 2014 128 136
15. C.K. Anders, and L.A. Carey Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer Clin Breast Cancer 9 Suppl. 2 2009 S73 S81
16. N.C. Turner, and J.S. Reis-Filho Tackling the diversity of triple-negative breast cancer Clin Cancer Res 19 2013 6380 6388
17. K.M. O'Brien, S.R. Cole, and C.K. Tse Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study Clin Cancer Res 16 2010 6100 6110
18. T. Sorlie, R. Tibshirani, and J. Parker Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 2003 8418 8423
19. R. Dent, M. Trudeau, and K.I. Pritchard Triple-negative breast cancer: clinical features and patterns of recurrence Clin Cancer Res 13 2007 4429 4434
20. N.U. Lin, E. Claus, and J. Sohl Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases Cancer 113 2008 2638 2645
21. S.J. Crabb, M.C. Cheang, and S. Leung Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer Clin Breast Cancer 8 2008 249 256
22. L. Wiechmann, M. Sampson, and M. Stempel Presenting features of breast cancer differ by molecular subtype Ann Surg Oncol 16 2009 2705 2710
23. K.A. Lee, and M.S. Jochelson Post breast conservation therapy imaging and local recurrence Q J Nucl Med Mol Imaging 57 2013 332 339
24. A.J. Lowery, M.R. Kell, and R.W. Glynn Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype Breast Cancer Res Treat 133 2012 831 841
25. B. Fisher, J. Dignam, and J. Bryant Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors J Natl Cancer Inst 88 1996 1529 1542
26. N.D. Arvold, A.G. Taghian, and A. Niemierko Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy J Clin Oncol 29 2011 3885 3891
27. E. Colzani, A.L. Johansson, and A. Liljegren Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics Br J Cancer 110 2014 1378 1384
28. K.D. Voduc, M.C. Cheang, and S. Tyldesley Breast cancer subtypes and the risk of local and regional relapse J Clin Oncol 28 2010 1684 1691
29. H. Kennecke, R. Yerushalmi, and R. Woods Metastatic behavior of breast cancer subtypes J Clin Oncol 28 2010 3271 3277
30. R. Dent, W.M. Hanna, and M. Trudeau Time to disease recurrence in basal-type breast cancers: effects of tumor size and lymph node status Cancer 115 2009 4917 4923
31. R. Dent, W.M. Hanna, and M. Trudeau Pattern of metastatic spread in triple-negative breast cancer Breast Cancer Res Treat 115 2009 423 428
32. T. Hamaoka, J.E. Madewell, and D.A. Podoloff Bone imaging in metastatic breast cancer J Clin Oncol 22 2004 2942 2953
33. C.M. Costelloe, E.M. Rohren, and J.E. Madewell Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis Lancet Oncol 10 2009 606 614
34. B.G. Haubold-Reuter, S. Duewell, and B.R. Schilcher The value of bone scintigraphy, bone marrow scintigraphy and fast spin-echo magnetic resonance imaging in staging of patients with malignant solid tumours: a prospective study Eur J Nucl Med 20 1993 1063 1069
35. G.J. Cook, and I. Fogelman The role of positron emission tomography in the management of bone metastases Cancer 88 12 Suppl. 2000 2927 2933
36. T.C. Lauenstein, S.C. Goehde, and C.U. Herborn Whole-body MR imaging: evaluation of patients for metastases Radiology 233 2004 139 148
37. C.M. Gaeta, J.L. Vercher-Conejero, and A.C. Sher Recurrent and metastatic breast cancer PET, PET/CT, PET/MRI: FDG and new biomarkers Q J Nucl Med Mol Imaging 57 2013 352 366
38. J. Rong, S. Wang, and Q. Ding Comparison of 18 FDG PET-CT and bone scintigraphy for detection of bone metastases in breast cancer patients. A meta-analysis Surg Oncol 22 2013 86 91
39. M. Smid, Y. Wang, and Y. Zhang Subtypes of breast cancer show preferential site of relapse Cancer Res 68 2008 3108 3114
40. H.S. Park, S. Kim, and K. Kim Pattern of distant recurrence according to the molecular subtypes in Korean women with breast cancer World J Surg Oncol 10 2012 4
41. F.B. Hagemeister Jr., A.U. Buzdar, and M.A. Luna Causes of death in breast cancer: a clinicopathologic study Cancer 46 1980 162 167
42. W.D. Foulkes, I.E. Smith, and J.S. Reis-Filho Triple-negative breast cancer New Engl J Med 363 2010 1938 1948
43. K.R. Hess, and F.J. Esteva Effect of HER2 status on distant recurrence in early stage breast cancer Breast Cancer Res Treat 137 2013 449 455
44. J.C. Mhlanga, A.E. Evans, and S. Doyle The prognostic significance of computerised tomography findings in women with liver metastases from breast cancer Breast 20 2011 455 459
45. P. Jha, L. Poder, and Z.J. Wang Radiologic mimics of cirrhosis AJR Am J Roentgenol 194 2010 993 999
46. F.M. Fennessy, K.J. Mortele, and T. Kluckert Hepatic capsular retraction in metastatic carcinoma of the breast occurring with increase or decrease in size of subjacent metastasis AJR Am J Roentgenol 182 2004 651 655
47. L. Braga, R.C. Semelka, and R. Pietrobon Does hypervascularity of liver metastases as detected on MRI predict disease progression in breast cancer patients? AJR Am J Roentgenol 182 2004 1207 1213
48. C.J. Zech, K.A. Herrmann, and M.F. Reiser MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA Magn Reson Med Sci 6 2007 43 52
49. K.R. Fink, and J.R. Fink Imaging of brain metastases Surg Neurol Int 4 Suppl. 4 2013 S209 S219
50. J.S. Barnholtz-Sloan, A.E. Sloan, and F.G. Davis Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System J Clin Oncol 22 2004 2865 2872
51. B. Leyland-Jones Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases J Clin Oncol 27 2009 5278 5286
52. J.C. Bendell, S.M. Domchek, and H.J. Burstein Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma Cancer 97 2003 2972 2977
53. E. Bria, F. Cuppone, and M. Fornier Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials Breast Cancer Res Treat 109 2008 231 239
54. M.A. Kaplan, H. Ertugrul, and U. Firat Brain metastases in HER2-positive metastatic breast cancer patients who received chemotherapy with or without trastuzumab Breast Cancer 2014, Jan 3 [Epub ahead of print. PMID: 24385387 ]
55. E.M. Olson, J.S. Najita, and J. Sohl Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era Breast 22 2013 525 531
56. N.U. Lin, L. Amiri-Kordestani, and D. Palmieri CNS metastases in breast cancer: old challenge, new frontiers Clin Cancer Res 19 2013 6404 6418
57. D.G. Hicks, S.M. Short, and N.L. Prescott Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR Am J Surg Pathol 30 2006 1097 1104
58. K. Lekanidi, A.L. Evans, and J. Shah Pattern of brain metastatic disease according to HER-2 and ER receptor status in breast cancer patients Clin Radiol 68 2013 1070 1073
59. J.E. Connolly Jr., J.J. Erasmus, and E.F. Patz Jr. Thoracic manifestations of breast carcinoma: metastatic disease and complications of treatment Clin Radiol 54 1999 487 494
60. N.U. Lin, A. Vanderplas, and M.E. Hughes Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network Cancer 118 2012 5463 5472
61. A.A. Luck, A.J. Evans, and A.R. Green The influence of basal phenotype on the metastatic pattern of breast cancer Clin Oncol (R Coll Radiol) 20 2008 40 45
62. J.I. Jung, H.H. Kim, and S.H. Park Thoracic manifestations of breast cancer and its therapy RadioGraphics 24 2004 1269 1285
63. L.S. Lindstrom, E. Karlsson, and U.M. Wilking Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression J Clin Oncol 30 2012 2601 2608
64. H.S. Lim, W. Yoon, and T.W. Chung FDG PET/CT for the detection and evaluation of breast diseases: usefulness and limitations RadioGraphics 27 Suppl. 1 2007 S197 S213
65. K.K. Miyake, Y. Nakamoto, and S. Kanao Diagnostic value of 18F-FDG PET/CT and MRI in predicting the clinicopathologic subtypes of invasive breast cancer AJR Am J Roentgenol 203 2014 272 279
66. G.L.K.F. Menezes, B.L. Stehouwer, and R.M. Pijnappel Magnetic resonance imaging in breast cancer: a literature review and future perspectives World J Clin Oncol 10 2014 61 70